Effects of Liver Disease on the Disposition of Ciramadol in Humans-Reference-Cited by-同舟云学术

Effects of Liver Disease on the Disposition of Ciramadol in Humans

Published:1989-03 Issue:3 Volume:29 Page:217-224
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Hoyumpa Anastacio M.,Brown Michael W.,Johnson Raymond,Troxell Rebecca,Snowdy Pam,Schenker Steven

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1989.tb03316.x/fullpdf

Reference26 articles.

1. Comparison of three doses of oral ciramadol and placebo for the treatment of moderate to severe postoperative pain;Fragen;J Clin Pharmacol,1982

2. Intramuscularly administered ciramadol for management of postoperative pain: a comparative study;Fragen;J Clin Pharmacol,1983

3. Oral ciramadol in the treatment of postoperative pain;Lasagna;Clin Pharmacol Ther,1985

4. A double-blind tial of single-dose ciramadol for the treatment of post-episiotomy pain;Defoort;Current Medical Research and Opinion,1982

5. Comparison of the analgesic efficacy and safety of oral ciramadol (ciradolR) to codeine and placebo in patients with chronic cancer pain;Stambaugh;Clin Pharmacol Ther,1983

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial II;British Journal of Anaesthesia;2002-06

2. Cholestasis as a liver protective factor in paracetamol acute overdose;General Pharmacology: The Vascular System;1995-11

3. 6 New agonist/antagonist analgesics;Baillière's Clinical Anaesthesiology;1995-03

4. Disposition of morphine and its glucuronide metabolites after oral and rectal administration: Evidence of route specificity;Clinical Pharmacology and Therapeutics;1993

5. Clinical Pharmacokinetics in Patients with Liver Disease;Clinical Pharmacokinetics;1991-07